Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

Clinical trial NCT07369024 · RECRUITING

Trial details

NCT number: NCT07369024
Sponsor: Mohsen Saidinejad
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Vaso-Occlusive Pain Episode in Sickle Cell Disease Ketamine Infusion Pain Management Vaso-Occlusive Crises

Start date: 2026-04-01
Primary completion: 2027-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.